Tridem Africa

pending

Tridem Pharma SAS (“Tridem”), together with Guilin Pharma, are planning to expand their pharmaceutical production capacity and distribution capabilities in French-speaking Africa through the construction of a regional pharmaceutical distribution hub in Cote d’Ivoire and the greenfield construction of a local drug manufacturing facility in Cote d’Ivoire (the “Project”). The manufacturing facility in Cote d’Ivoire will primarily be used to manufacture life-saving anti-malaria drugs. The proposed IFC investment comprises of two A loans to the local subsidiaries of Tridem and Guilin Pharma for the implementation of the Project.Tridem is a French pharmaceutical distribution company with a substantial presence in Africa, which offers distribution solutions for pharmaceutical manufacturers, including regulatory affairs and licensing, promotion, distribution. Guilin Pharma is a Chinese pharmaceutical company and a leading producer of anti-malarial products, with its products being made available in over 80 countries globally.